Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1991 Feb;154(2):186–197.

Brain tumors.

K L Black 1, J C Mazziotta 1, D P Becker 1
PMCID: PMC1002710  PMID: 1848735

Abstract

Recent advances in experimental tumor biology are being applied to critical clinical problems of primary brain tumors. The expression of peripheral benzodiazepine receptors, which are sparse in normal brain, is increased as much as 20-fold in brain tumors. Experimental studies show promise in using labeled ligands to these receptors to identify the outer margins of malignant brain tumors. Whereas positron emission tomography has improved the dynamic understanding of tumors, the labeled selective tumor receptors with positron emitters will enhance the ability to specifically diagnose and greatly aid in the pretreatment planning for tumors. Modulation of these receptors will also affect tumor growth and metabolism. Novel methods to deliver antitumor agents to the brain and new approaches using biologic response modifiers also hold promise to further improve the management of brain tumors.

Full text

PDF
186

Images in this article

187Image
on p.187
190Image
on p.190
191Image
on p.191
192Image
on p.192
192Image
on p.192
194Image
on p.194
194Image
on p.194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alavi J. B., Alavi A., Chawluk J., Kushner M., Powe J., Hickey W., Reivich M. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer. 1988 Sep 15;62(6):1074–1078. doi: 10.1002/1097-0142(19880915)62:6<1074::aid-cncr2820620609>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Anholt R. R., Pedersen P. L., De Souza E. B., Snyder S. H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986 Jan 15;261(2):576–583. [PubMed] [Google Scholar]
  3. Arnold J. B., Kraig R. P., Rottenberg D. A. In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography. II: Characterization of the extracellular fluid compartment using pH-sensitive microelectrodes and [14C]sucrose. J Cereb Blood Flow Metab. 1986 Aug;6(4):435–440. doi: 10.1038/jcbfm.1986.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Basile A. S., Skolnick P. Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain. J Neurochem. 1986 Jan;46(1):305–308. doi: 10.1111/j.1471-4159.1986.tb12965.x. [DOI] [PubMed] [Google Scholar]
  5. Beaney R. P., Brooks D. J., Leenders K. L., Thomas D. G., Jones T., Halnan K. E. Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. J Neurol Neurosurg Psychiatry. 1985 Apr;48(4):310–319. doi: 10.1136/jnnp.48.4.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beaney R. P., Lammertsma A. A., Jones T., McKenzie C. G., Halnan K. E. Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet. 1984 Jan 21;1(8369):131–134. doi: 10.1016/s0140-6736(84)90063-1. [DOI] [PubMed] [Google Scholar]
  7. Beaney R. P. Positron emission tomography in the study of human tumors. Semin Nucl Med. 1984 Oct;14(4):324–341. doi: 10.1016/s0001-2998(84)80006-9. [DOI] [PubMed] [Google Scholar]
  8. Bergström M., Collins V. P., Ehrin E., Ericson K., Eriksson L., Greitz T., Halldin C., von Holst H., Långström B., Lilja A. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr. 1983 Dec;7(6):1062–1066. doi: 10.1097/00004728-198312000-00022. [DOI] [PubMed] [Google Scholar]
  9. Black K. L., Hawkins R. A., Kim K. T., Becker D. P., Lerner C., Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg. 1989 Sep;71(3):342–346. doi: 10.3171/jns.1989.71.3.0342. [DOI] [PubMed] [Google Scholar]
  10. Black K. L., Ikezaki K., Santori E., Becker D. P., Vinters H. V. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man. Cancer. 1990 Jan 1;65(1):93–97. doi: 10.1002/1097-0142(19900101)65:1<93::aid-cncr2820650120>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  11. Black K. L., Ikezaki K., Toga A. W. Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J Neurosurg. 1989 Jul;71(1):113–118. doi: 10.3171/jns.1989.71.1.0113. [DOI] [PubMed] [Google Scholar]
  12. Brooks D. J., Beaney R. P., Thomas D. G., Marshall J., Jones T. Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography. J Cereb Blood Flow Metab. 1986 Oct;6(5):529–535. doi: 10.1038/jcbfm.1986.98. [DOI] [PubMed] [Google Scholar]
  13. Brooks D. J., Beaney R. P., Thomas D. G. The role of positron emission tomography in the study of cerebral tumors. Semin Oncol. 1986 Mar;13(1):83–93. [PubMed] [Google Scholar]
  14. Brownell G. L., Kairento A. L., Swartz M., Elmaleh D. R. Positron emission tomography in oncology--the Massachusetts General Hospital experience. Semin Nucl Med. 1985 Apr;15(2):201–209. doi: 10.1016/s0001-2998(85)80026-x. [DOI] [PubMed] [Google Scholar]
  15. Clarke G. D., Ryan P. J. Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells. Nature. 1980 Sep 11;287(5778):160–161. doi: 10.1038/287160a0. [DOI] [PubMed] [Google Scholar]
  16. Curran T., Morgan J. I. Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science. 1985 Sep 20;229(4719):1265–1268. doi: 10.1126/science.4035354. [DOI] [PubMed] [Google Scholar]
  17. De Souza E. B., Anholt R. R., Murphy K. M., Snyder S. H., Kuhar M. J. Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology. 1985 Feb;116(2):567–573. doi: 10.1210/endo-116-2-567. [DOI] [PubMed] [Google Scholar]
  18. DeLaPaz R. L., Patronas N. J., Brooks R. A., Smith B. H., Kornblith P. L., Milam H., Di Chiro G. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):826–829. [PMC free article] [PubMed] [Google Scholar]
  19. Di Chiro G. Brain imaging of glucose utilization in cerebral tumors. Res Publ Assoc Res Nerv Ment Dis. 1985;63:185–197. [PubMed] [Google Scholar]
  20. Di Chiro G., Brooks R. A., Patronas N. J., Bairamian D., Kornblith P. L., Smith B. H., Mansi L., Barker J. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol. 1984;15 (Suppl):S138–S146. doi: 10.1002/ana.410150727. [DOI] [PubMed] [Google Scholar]
  21. Di Chiro G., DeLaPaz R. L., Brooks R. A., Sokoloff L., Kornblith P. L., Smith B. H., Patronas N. J., Kufta C. V., Kessler R. M., Johnston G. S. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 1982 Dec;32(12):1323–1329. doi: 10.1212/wnl.32.12.1323. [DOI] [PubMed] [Google Scholar]
  22. Di Chiro G., Oldfield E., Bairamian D., Patronas N. J., Brooks R. A., Mansi L., Smith B. H., Kornblith P. L., Margolin R. Metabolic imaging of the brain stem and spinal cord: studies with positron emission tomography using 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr. 1983 Dec;7(6):937–945. doi: 10.1097/00004728-198312000-00001. [DOI] [PubMed] [Google Scholar]
  23. Di Chiro G., Oldfield E., Wright D. C., De Michele D., Katz D. A., Patronas N. J., Doppman J. L., Larson S. M., Ito M., Kufta C. V. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol. 1988 Jan;150(1):189–197. doi: 10.2214/ajr.150.1.189. [DOI] [PubMed] [Google Scholar]
  24. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol. 1987 May;22(5):360–371. doi: 10.1097/00004424-198705000-00002. [DOI] [PubMed] [Google Scholar]
  25. Diwan B. A., Rice J. M., Ward J. M. Tumor-promoting activity of benzodiazepine tranquilizers, diazepam and oxazepam, in mouse liver. Carcinogenesis. 1986 May;7(5):789–794. doi: 10.1093/carcin/7.5.789. [DOI] [PubMed] [Google Scholar]
  26. Doyle W. K., Budinger T. F., Valk P. E., Levin V. A., Gutin P. H. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr. 1987 Jul-Aug;11(4):563–570. doi: 10.1097/00004728-198707000-00001. [DOI] [PubMed] [Google Scholar]
  27. Earnest F., 4th, Kelly P. J., Scheithauer B. W., Kall B. A., Cascino T. L., Ehman R. L., Forbes G. S., Axley P. L. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology. 1988 Mar;166(3):823–827. doi: 10.1148/radiology.166.3.2829270. [DOI] [PubMed] [Google Scholar]
  28. Gallager D. W., Mallorga P., Oertel W., Henneberry R., Tallman J. [3H]Diazepam binding in mammalian central nervous system: a pharmacological characterization. J Neurosci. 1981 Feb;1(2):218–225. doi: 10.1523/JNEUROSCI.01-02-00218.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ginos J. Z., Cooper A. J., Dhawan V., Lai J. C., Strother S. C., Alcock N., Rottenberg D. A. [13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med. 1987 Dec;28(12):1844–1852. [PubMed] [Google Scholar]
  30. Hawkins R. A., Huang S. C., Barrio J. R., Keen R. E., Feng D., Mazziotta J. C., Phelps M. E. Estimation of local cerebral protein synthesis rates with L-[1-11C]leucine and PET: methods, model, and results in animals and humans. J Cereb Blood Flow Metab. 1989 Aug;9(4):446–460. doi: 10.1038/jcbfm.1989.68. [DOI] [PubMed] [Google Scholar]
  31. Hawkins R. A., Phelps M. E., Huang S. C., Wapenski J. A., Grimm P. D., Parker R. G., Juillard G., Greenberg P. A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography. J Cereb Blood Flow Metab. 1984 Dec;4(4):507–515. doi: 10.1038/jcbfm.1984.75. [DOI] [PubMed] [Google Scholar]
  32. Hawkins R. A., Phelps M. E. PET in clinical oncology. Cancer Metastasis Rev. 1988 Jun;7(2):119–142. doi: 10.1007/BF00046482. [DOI] [PubMed] [Google Scholar]
  33. Hossmann K. A., Niebuhr I., Tamura M. Local cerebral blood flow and glucose consumption of rats with experimental gliomas. J Cereb Blood Flow Metab. 1982;2(1):25–32. doi: 10.1038/jcbfm.1982.3. [DOI] [PubMed] [Google Scholar]
  34. Hullihan J. P., Spector S., Taniguchi T., Wang J. K. The binding of [3H]-diazepam to guinea-pig ileal longitudinal muscle and the in vitro inhibition of contraction by benzodiazepines. Br J Pharmacol. 1983 Feb;78(2):321–327. doi: 10.1111/j.1476-5381.1983.tb09397.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ito M., Lammertsma A. A., Wise R. J., Bernardi S., Frackowiak R. S., Heather J. D., McKenzie C. G., Thomas D. G., Jones T. Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumours using 15O and positron emission tomography: analytical techniques and preliminary results. Neuroradiology. 1982;23(2):63–74. doi: 10.1007/BF00367239. [DOI] [PubMed] [Google Scholar]
  36. Jarden J. O., Dhawan V., Poltorak A., Posner J. B., Rottenberg D. A. Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb: the effect of dexamethasone and whole-brain radiation therapy. Ann Neurol. 1985 Dec;18(6):636–646. doi: 10.1002/ana.410180603. [DOI] [PubMed] [Google Scholar]
  37. Johnson M. D., Wang J. K., Morgan J. I., Spector S. Downregulation of [3H]Ro5-4864 binding sites after exposure to peripheral-type benzodiazepines in vitro. J Pharmacol Exp Ther. 1986 Sep;238(3):855–859. [PubMed] [Google Scholar]
  38. Marangos P. J., Patel J., Boulenger J. P., Clark-Rosenberg R. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol. 1982 Jul;22(1):26–32. [PubMed] [Google Scholar]
  39. Matthew E., Laskin J. D., Zimmerman E. A., Weinstein I. B., Hsu K. C., Engelhardt D. L. Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3935–3939. doi: 10.1073/pnas.78.6.3935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Miraldi F. Potential of NMR and PET for determining tumor metabolism. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1033–1039. doi: 10.1016/0360-3016(86)90221-x. [DOI] [PubMed] [Google Scholar]
  41. Muhr C., Bergström M., Lundberg P. O., Bergström K., Hartvig P., Lundqvist H., Antoni G., Långström B. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. J Comput Assist Tomogr. 1986 Mar-Apr;10(2):175–180. doi: 10.1097/00004728-198603000-00001. [DOI] [PubMed] [Google Scholar]
  42. Patronas N. J., Brooks R. A., DeLaPaz R. L., Smith B. H., Kornblith P. L., Di Chiro G. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):533–535. [PMC free article] [PubMed] [Google Scholar]
  43. Patronas N. J., Di Chiro G., Brooks R. A., DeLaPaz R. L., Kornblith P. L., Smith B. H., Rizzoli H. V., Kessler R. M., Manning R. G., Channing M. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology. 1982 Sep;144(4):885–889. doi: 10.1148/radiology.144.4.6981123. [DOI] [PubMed] [Google Scholar]
  44. Patronas N. J., Di Chiro G., Kufta C., Bairamian D., Kornblith P. L., Simon R., Larson S. M. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 1985 Jun;62(6):816–822. doi: 10.3171/jns.1985.62.6.0816. [DOI] [PubMed] [Google Scholar]
  45. Patronas N. J., Di Chiro G., Smith B. H., De La Paz R., Brooks R. A., Milam H. L., Kornblith P. L., Bairamian D., Mansi L. Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res. 1984 Jan 16;291(1):93–101. doi: 10.1016/0006-8993(84)90654-1. [DOI] [PubMed] [Google Scholar]
  46. Pawlikowski M., Kunert-Radek J., Radek A., Stepien H. Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro. Acta Neurol Scand. 1988 Mar;77(3):231–233. doi: 10.1111/j.1600-0404.1988.tb05900.x. [DOI] [PubMed] [Google Scholar]
  47. Phelps M. E., Huang S. C., Hoffman E. J., Selin C., Sokoloff L., Kuhl D. E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979 Nov;6(5):371–388. doi: 10.1002/ana.410060502. [DOI] [PubMed] [Google Scholar]
  48. Phelps M. E., Mazziotta J. C. Positron emission tomography: human brain function and biochemistry. Science. 1985 May 17;228(4701):799–809. doi: 10.1126/science.2860723. [DOI] [PubMed] [Google Scholar]
  49. Phillips P. C., Dhawan V., Strother S. C., Sidtis J. J., Evans A. C., Allen J. C., Rottenberg D. A. Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study. Ann Neurol. 1987 Jan;21(1):59–63. doi: 10.1002/ana.410210111. [DOI] [PubMed] [Google Scholar]
  50. Positron emission tomography in oncology. Council on Scientific Affairs. JAMA. 1988 Apr 8;259(14):2126–2131. [PubMed] [Google Scholar]
  51. Reivich M., Kuhl D., Wolf A., Greenberg J., Phelps M., Ido T., Casella V., Fowler J., Hoffman E., Alavi A. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979 Jan;44(1):127–137. doi: 10.1161/01.res.44.1.127. [DOI] [PubMed] [Google Scholar]
  52. Rhodes C. G., Wise R. J., Gibbs J. M., Frackowiak R. S., Hatazawa J., Palmer A. J., Thomas D. G., Jones T. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol. 1983 Dec;14(6):614–626. doi: 10.1002/ana.410140604. [DOI] [PubMed] [Google Scholar]
  53. Richfield E. K., Ciliax B. J., Starosta-Rubinstein S. R., McKeever P. E., Penney J. B., Young A. B. Comparison of [14C]-deoxyglucose metabolism and peripheral benzodiazepine receptor binding in rat C6 glioma. Neurology. 1988 Aug;38(8):1255–1262. doi: 10.1212/wnl.38.8.1255. [DOI] [PubMed] [Google Scholar]
  54. Rottenberg D. A., Ginos J. Z., Kearfott K. J., Junck L., Dhawan V., Jarden J. O. In vivo measurement of brain tumor pH using [11C]DMO and positron emission tomography. Ann Neurol. 1985 Jan;17(1):70–79. doi: 10.1002/ana.410170116. [DOI] [PubMed] [Google Scholar]
  55. Ruff M. R., Pert C. B., Weber R. J., Wahl L. M., Wahl S. M., Paul S. M. Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science. 1985 Sep 20;229(4719):1281–1283. doi: 10.1126/science.2994216. [DOI] [PubMed] [Google Scholar]
  56. Schoemaker H., Boles R. G., Horst W. D., Yamamura H. I. Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther. 1983 Apr;225(1):61–69. [PubMed] [Google Scholar]
  57. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
  58. Squires R. F., Brastrup C. Benzodiazepine receptors in rat brain. Nature. 1977 Apr 21;266(5604):732–734. doi: 10.1038/266732a0. [DOI] [PubMed] [Google Scholar]
  59. Starosta-Rubinstein S., Ciliax B. J., Penney J. B., McKeever P., Young A. B. Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci U S A. 1987 Feb;84(3):891–895. doi: 10.1073/pnas.84.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Syapin P. J., Skolnick P. Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem. 1979 Mar;32(3):1047–1051. doi: 10.1111/j.1471-4159.1979.tb04592.x. [DOI] [PubMed] [Google Scholar]
  61. Tallman J. F., Gallager D. W. The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci. 1985;8:21–44. doi: 10.1146/annurev.ne.08.030185.000321. [DOI] [PubMed] [Google Scholar]
  62. Tallman J. F., Paul S. M., Skolnick P., Gallager D. W. Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science. 1980 Jan 18;207(4428):274–281. doi: 10.1126/science.6101294. [DOI] [PubMed] [Google Scholar]
  63. Tallman J. F., Thomas J. W., Gallager D. W. GABAergic modulation of benzodiazepine binding site sensitivity. Nature. 1978 Jul 27;274(5669):383–385. doi: 10.1038/274383a0. [DOI] [PubMed] [Google Scholar]
  64. Tamargo R. J., Epstein J. I., Reinhard C. S., Chasin M., Brem H. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J Biomed Mater Res. 1989 Feb;23(2):253–266. doi: 10.1002/jbm.820230209. [DOI] [PubMed] [Google Scholar]
  65. Thomas D. G., Beaney R. P., Brooks D. J. Positron emission tomography in the study of cerebral tumours. Neurosurg Rev. 1984;7(4):253–258. doi: 10.1007/BF01892906. [DOI] [PubMed] [Google Scholar]
  66. Tyler J. L., Diksic M., Villemure J. G., Evans A. C., Meyer E., Yamamoto Y. L., Feindel W. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med. 1987 Jul;28(7):1123–1133. [PubMed] [Google Scholar]
  67. Tyler J. L., Yamamoto Y. L., Diksic M., Théron J., Villemure J. G., Worthington C., Evans A. C., Feindel W. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET. J Nucl Med. 1986 Jun;27(6):775–780. [PubMed] [Google Scholar]
  68. Valk P. E., Budinger T. F., Levin V. A., Silver P., Gutin P. H., Doyle W. K. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg. 1988 Dec;69(6):830–838. doi: 10.3171/jns.1988.69.6.0830. [DOI] [PubMed] [Google Scholar]
  69. Walker M. D., Strike T. A., Sheline G. E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1725–1731. doi: 10.1016/0360-3016(79)90553-4. [DOI] [PubMed] [Google Scholar]
  70. Wallner K. E., Galicich J. H., Krol G., Arbit E., Malkin M. G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405–1409. doi: 10.1016/0360-3016(89)90941-3. [DOI] [PubMed] [Google Scholar]
  71. Wang J. K., Morgan J. I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci U S A. 1984 Feb;81(3):753–756. doi: 10.1073/pnas.81.3.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Wang J. K., Taniguchi T., Spector S. Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Mol Pharmacol. 1984 May;25(3):349–351. [PubMed] [Google Scholar]
  73. Wastek G. J., Speth R. C., Reisine T. D., Yamamura H. I. The effect of gamma-aminobutyric acid on 3H-flunitrazepam binding in rat brain. Eur J Pharmacol. 1978 Aug 15;50(4):445–447. doi: 10.1016/0014-2999(78)90152-8. [DOI] [PubMed] [Google Scholar]
  74. Weber G. Enzymology of cancer cells (first of two parts). N Engl J Med. 1977 Mar 3;296(9):486–492. doi: 10.1056/NEJM197703032960905. [DOI] [PubMed] [Google Scholar]
  75. Whitehouse P. J. Intraventricular bethanechol in Alzheimer's disease: a continuing controversy. Neurology. 1988 Feb;38(2):307–308. doi: 10.1212/wnl.38.2.307. [DOI] [PubMed] [Google Scholar]
  76. Wilson C. B., Boldrey E. B., Enot K. J. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemother Rep. 1970 Aug;54(4):273–281. [PubMed] [Google Scholar]
  77. Winger M. J., Macdonald D. R., Cairncross J. G. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg. 1989 Oct;71(4):487–493. doi: 10.3171/jns.1989.71.4.0487. [DOI] [PubMed] [Google Scholar]
  78. Wise R. J., Thomas D. G., Lammertsma A. A., Rhodes C. G. PET scanning of human brain tumors. Prog Exp Tumor Res. 1984;27:154–169. doi: 10.1159/000408228. [DOI] [PubMed] [Google Scholar]
  79. Yamamoto Y. L., Thompson C. J., Meyer E., Robertson J. S., Feindel W. Dynamic positron emission tomography for study of cerebral hemodynamics in a cross section of the head using positron-emitting 68Ga-EDTA and 77Kr. J Comput Assist Tomogr. 1977 Jan;1(1):43–56. doi: 10.1097/00004728-197701000-00007. [DOI] [PubMed] [Google Scholar]
  80. Yen C. K., Yano Y., Budinger T. F., Friedland R. P., Derenzo S. E., Huesman R. H., O'Brien H. A. Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med. 1982 Jun;23(6):532–537. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES